about
Structure-function analysis of LIV-1, the breast cancer-associated protein that belongs to a new subfamily of zinc transportersStructure-function analysis of a novel member of the LIV-1 subfamily of zinc transporters, ZIP14Structure-function analysis of HKE4, a member of the new LIV-1 subfamily of zinc transportersThe emerging role of the LIV-1 subfamily of zinc transporters in breast cancerThe Urolift System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A NICE Medical Technology GuidanceTENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independenceSocial inequality and infant health in the UK: systematic review and meta-analyses.Transcription of the vasoactive intestinal peptide gene in response to glucocorticoids: differential regulation of alternative transcripts is modulated by a labile protein in rat anterior pituitary.ENDURALIFE-Powered Cardiac Resynchronisation Therapy Defibrillator Devices for Treating Heart Failure: A NICE Medical Technology Guidance.Analysis of a National Programme for Selective Internal Radiation Therapy for Colorectal Cancer Liver MetastasesThe CINAHL database: a guide for hospital pharmacistsRepression of vasopressin gene expression by glucocorticoids in transgenic mice: evidence of a direct mechanism mediated by proximal 5′ flanking sequenceThopaz+ Portable Digital System for Managing Chest Drains: A NICE Medical Technology Guidance.iFuse Implant System for Treating Chronic Sacroiliac Joint Pain: A NICE Medical Technology GuidancePeristeen Transanal Irrigation System to Manage Bowel Dysfunction: A NICE Medical Technology Guidance
P50
Q24306742-26EB2782-80B9-42F5-9AA2-5443509E9BF0Q24337728-134A046C-613F-4B5A-AE08-D802D96F14E3Q24530609-3E783408-EAA9-4B7B-A640-77DC380DE97CQ24682854-A9A37E08-2F77-4043-BCF2-B2C71024D097Q28074511-EEC94D16-9CD8-47EB-BEF2-E7484665DB44Q28201559-879ADE9D-6D08-4C99-9D6D-E1F01921871CQ36045095-5016C308-E34A-4254-90A0-FC11275CB18EQ41104133-BB747CED-ED65-42C2-9420-E73A92EF63A2Q47230200-20F0E943-DA1C-441C-A9B4-9E4B264F10A6Q57297324-49F49F58-3EEE-4713-9486-A10A9D913137Q58181389-DB6C5A64-0FE2-42EA-83DA-451E88F1B3E0Q58181431-DF354310-B485-4788-A235-3834019F5C2EQ64883210-2A9EB659-8A56-443C-AAF2-DCA4B7164D07Q92268986-F589B916-7D37-4B28-A594-4CD0A56A280BQ93063263-11C2374E-DCEE-4DC4-93CB-E457FE0A6A0B
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-2470-9746
@en
name
Helen E Morgan
@ast
Helen E Morgan
@en
Helen E Morgan
@es
Helen E Morgan
@nl
type
label
Helen E Morgan
@ast
Helen E Morgan
@en
Helen E Morgan
@es
Helen E Morgan
@nl
prefLabel
Helen E Morgan
@ast
Helen E Morgan
@en
Helen E Morgan
@es
Helen E Morgan
@nl
P106
P1153
7202308961
P31
P496
0000-0003-2470-9746